LONGEVITAS S.R.L.

For a long time, medicine focused primarily on curing illness. Longevity medicine inverts this logic: the goal is not to intervene once something has gone wrong, but to understand the mechanisms of biological ageing in advance and act to slow them, preserving energy, health, and performance over time. Longevitas, based in Avigliana with clinical activity in Turin, is one of the Italian organisations that has chosen to operate in this space. The proposition is that of a clinic specialised in advanced preventive medicine: in-depth assessments that go well beyond standard parameters, personalised programmes built around each patient's individual biology, and treatments designed to improve not only objective health markers but also the perceived quality of energy and daily performance. Longevitas's target audience includes professionals, executives, athletes, and anyone who wants to engage with ageing proactively, grounded in scientific data and personalised protocols. The B2B model also opens pathways to collaboration with clinics, healthcare professionals, and digital health platforms interested in integrating longevity programmes into their own offering. The global preventive medicine and longevity market is growing rapidly: rising awareness around healthspan — not just how many years one lives, but how many of those are lived in full health — is driving demand that traditional healthcare models are ill-equipped to satisfy. Longevitas positions itself as a structured response to this emerging demand, combining clinical rigour with a genuinely personalised approach.